(Q43805861)

English

Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column

scientific article published in January 1989

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Balzarini J

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cools M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

De Clercq E

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

413-422

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Antiviral activity of 2',3'-dideoxycytidin-2'-ene (2',3'-dideoxy-2',3'-didehydrocytidine) against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

The AIDS dementia complex: I. Clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2889%2980063-4

7 January 2021

Identifiers

10.1016/S0006-291X(89)80063-4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43805861&oldid=2189468981"